Reduction of nasal lesions and production losses after vaccination against non-progressive atrophic rhinitis
A new study demonstrates the efficacy of vaccination against NPAR.
18 July 2019
4 minute read
By: 
*a,b: Statistically significant differences (P values <0.01) at the same parameter are indicated with defferent superscripts.
| References | ||||
|---|---|---|---|---|
| 1. Hammond, EE et al. | ||||
| (2009) | . Zoo Wildl Med | 40:369-372 | ||
| 2. Comission notice | ||||
| (2015) | . official Journal of the European Union | 2015/C 299/04 | ||
| 3. Magyar, T et al. | ||||
| (2002) | Evaluation of vaccines for atrophic rhinitis - a comparison of three challenge models.. Vaccine | 20: 1797-1802 | ||
| 4. European pharmacopeia 8.0 | ||||
| (2004) | . Monograph | 01/2004:1361 | ||
| 5. Sanchez-Matamoros, A et al. | ||||
| (2017) | Field efficacy study of RHINISENG® in Europe in a farm with problems associated with Bordetella bronchiseptia.. AAASV |
